The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients (Q34329426)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients |
scientific article |
Statements
1 reference
The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients (English)
1 reference
Bernard Charbonnel
1 reference
John Dormandy
1 reference
Erland Erdmann
1 reference
Massimo Massi-Benedetti
1 reference
Allan Skene
1 reference
PROactive Study Group
1 reference
1 reference
Identifiers
1 reference